Told too late about drug error: Eastern Health CEO - Action News
Home WebMail Saturday, November 23, 2024, 11:59 PM | Calgary | -12.4°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
NL

Told too late about drug error: Eastern Health CEO

The head of Newfoundland and Labrador's largest health authority said Friday she should have been told sooner about a problem with the way the Health Sciences Centre in St. John's was administering the drug cyclosporine.

The head of Newfoundland and Labrador's largesthealth authority said Friday she should have been told sooner about a problem with the way the Health Sciences Centre in St. John's was administering the drug cyclosporine.

Eastern Health CEO Vickie Kaminski said she only learned that some of the hospital'spatients might have gotten the wrong dose of the drug11 days after a nurse warned staff about the problem.

"I think we should have known sooner," Kaminski said. "And certainly, that's what we will look at. Was it reasonable for us to know that sooner? And if so, why not? Why weren't we [told]?"

Cyclosporine suppresses the immune system and is used to prevent organ rejection in transplant patients and to treat symptoms of autoimmune diseases like lupus and rheumatoid arthritis.

In early February, a nurse told hospital staff in St. John's that she was concerned about the doses of cyclosporine some patients were receiving.

In mid-February, doctors realized a seriously ill 14-year-old patient might have been given too much of the immunosuppressant, which can cause kidney damage.

Kaminski said she found out about the problem on Feb. 19 after the teenager became sicker and had to be admitted to intensive care.

Although Kaminskihad told mediaearlier Friday that the teen was out of intensive care, Eastern Health corrected that detail Friday evening and said the14-year-old wasstill in intensive care.

A patient review that began before Kaminski was told about the problem found that234 patientshad receivedcyclosporine in the ninemonths since the hospital began using a new machine for testing levels of the drugin a patient's blood. The bloodwork of those patientsis now being retested in Halifax.

Kaminski said 13 of the patients died during the nine-month period, but there is no reason to believe any of their deaths were related to the amount of cyclosporine they received.

She said it's believed that the dosing problem began when an employee of the hospital'sbiochemistry lab incorrectly calibratedthe newmachine.

An Eastern Health quality-control team is looking into what went wrong in the lab. It is expected to report its findings, which Kaminiski said will be made public,next week.

A group from the University Health Network in Toronto is to begin a review next week of Eastern Health's laboratory services.